Wednesday, September 9, 2020 9:30 am – 3:45 pm


Click here to download agenda

9:15 am

Zoom Line Open

9:30 am

Welcome & Opening Remarks
Moderator: Amy Goldstein, PhD, Prevention Research Branch Chief, National Institute on Drug Abuse, NIH

Lawrence A. Tabak, DDS, PhD, Principal Deputy Director, National Institutes of Health

Rebecca G. Baker, PhD, Director, HEAL Initiative, National Institutes of Health

Nora D. Volkow, MD, Director, National Institute on Drug Abuse, NIH

10:00 am

Keynote Address:
Relationship of Social Determinants to Early Drug Use, Opioid and Psychostimulant Use, Polydrug Use, and Injection Drug Use

Moderator: Aria Crump, ScD, Prevention Research Deputy Branch Chief, National Institute on Drug Abuse, NIH

Keynote Speaker:
Sandro Galea, MD, DrPH, Dean and Robert A. Knox Professor, Boston University School of Public Health

10:30 am

Session 1:
Framework: Understanding the Role of Social and Community Factors in the Context of Past and Present Inequities

Moderator: Jennifer Alvidrez, PhD, Community Health and Population Sciences Program Director, National Institute on Minority Health and Health Disparities, NIH

Debra Furr-Holden, PhD., C.S. Mott Endowed Professor of Public Health; Associate Dean for Public Health Integration and Director of the Flint Center for Health Equity Solutions, Michigan State University

Hillary Kunins, MD, MPH, Executive Deputy Commissioner of Mental Hygiene, New York City Department of Health; Mental Hygiene and Clinical Professor, Albert Einstein College of Medicine

Donald Warne, MD, MPH, Associate Dean, Diversity, Equity and Inclusion, School of Medicine and Health Sciences, University of North Dakota; Director, Indians Into Medicine (INMED) Program and Director, Public Health Program, University of North Dakota

Andrea Hussong, PhD, Professor, Psychology and Neuroscience, University of North Carolina at Chapel Hill

11:30 am

Session 2:
Mechanisms: Pathways of Influence of Social Determinants on Opioid-Related Outcomes

Moderator: Erica Spotts, PhD, Health Scientist Administrator, Office of Behavioral and Social Sciences Research, NIH

Shannon Monnat, PhD, Lerner Chair and Director of the Lerner Center for Public Health Promotion, Syracuse University

Velma McBride Murry, PhD, Lois Autrey Betts Chair, Education and Human Development, University Professor, Vanderbilt University Medical Center and Peabody College of Vanderbilt University

Joshua Sharfstein, MD, Vice Dean for Public Health Practice and Community Engagement, Johns Hopkins University

Philip Fisher, PhD, Philip H. Knight Chair & Professor of Psychology; Director, Center for Translational Neuroscience, University of Oregon

12:30 pm


1:00 pm

Zoom Line Open

1:15 pm

Morning Summary and Afternoon Overview
Carlos Blanco, MD, Director, Division of Epidemiology, Services and Prevention Research, NIDA

1:25 pm

Session 3:
Interventions: Strategies to Intervene on Social Factors at the Interpersonal, Community, and System Levels

Moderator: Jacqueline Lloyd, PhD, MSW, Senior Advisor, Office of Disease Prevention, NIH

Deborah Gorman-Smith, PhD, Dean and Emily Klein Gidwitz Professor, School of Social Service Administration, University of Chicago

Karen Hellman, MA, Assistant Director, Inmate Programs and Reentry, Arizona Department of Corrections, Rehabilitation & Reentry

Kelly J. Kelleher, MD, Distinguished Professor of Pediatrics and Public Health and ADS Chair for Innovation in Pediatric Practice in the Colleges of Medicine and Public Health, The Ohio State University

Allison Barlow, PhD, MPH, Director, Center for American Indian Health, Johns Hopkins University

Phillip Graham, DrPH, Director, Center on Social Determinants, Risk Behaviors, and Prevention Science, RTI International

2:30 pm

Session 4:
Adoption and Scale Up: Moving Social Interventions to Practice to Reduce Opioid Use and Other Drug Use Disorders

Moderator: Frank Bandiera, PhD, MPH, Division of Behavioral and Social Research, National Institute on Aging

Gail Maddox Taylor, MEd, Director, Office of Behavioral Health Wellness, Commonwealth of Virginia

Craig PoVey, MSW, Prevention Administrator, Utah Division of Substance Abuse and Mental Health

Alison E. Cuellar, PhD, Professor, Health Administration and Policy, George Mason University; Vice Chair, CDC Community Preventive Services Task Force

Natasha Underwood, PhD, MPH, Health Scientist, Applied Prevention Science Team, Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention

Cherie Rooks-Peck, PhD, Lead Health Scientist and Team Lead of the Applied Prevention Science Team, Division of Overdose Prevention, Centers for Disease Control and Prevention

3:30 pm

Meeting Summary and Next Steps
Nora D. Volkow, MD, Director, National Institute on Drug Abuse, NIH

Monica Webb Hooper, PhD, Deputy Director, National Institute on Minority Health and Health Disparities, NIH

3:45 pm